VRSN
60
3
PYPL
58
2
KLAC
63
-5
DIS
68
3
VRSK
54
16
MCK
46
2
CME
50
-8
USB
51
-2
CPB
55
-2
NRG
72
-2
GILD
54
3
SRCL
44
-11
APH
55
-4
YUM
56
4
NWL
57
3
UNH
57
4
DE
56
3
PVH
58
4
SWN
82
2
AAL
62
-3
VRSN
60
3
PYPL
58
2
KLAC
63
-5
DIS
68
3
VRSK
54
16
MCK
46
2
CME
50
-8
USB
51
-2
CPB
55
-2
NRG
72
-2
GILD
54
3
SRCL
44
-11
APH
55
-4
YUM
56
4
NWL
57
3
UNH
57
4
DE
56
3
PVH
58
4
SWN
82
2
AAL
62
-3
Financhill
Back

Invesco S&P MidCap Value with Momt ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
68

XMVM
Invesco S&P MidCap Value with Momt ETF

Last Price:
55.15
Seasonality Move:
5.05%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
68
Invesco S&P MidCap Value with Momt ETF (XMVM) is a Buy

Is Invesco S&P MidCap Value with Momt ETF a Buy, Sell or Hold?

  • The current Invesco S&P MidCap Value with Momt ETF [XMVM] share price is $55.27. The Score for XMVM is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • XMVM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XMVM Stock Price Chart

What is Invesco S&P MidCap Value with Momt ETF's stock price today?

  • The Invesco S&P MidCap Value with Momt ETF share price today is $55.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XMVM is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

XMVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 56.23 Buy
Chaikin Money Flow: -772 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.32 - 55.72) Buy
Bollinger Bands (100): (51.79 - 54.89) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

XMVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.25 Buy
20-day SMA: 54.26 Buy
50-day SMA: 54.25 Buy
200-day SMA: 52.04 Buy
8-day EMA: 54.96 Buy
20-day EMA: 54.58 Buy
50-day EMA: 54.08 Buy
200-day EMA: 51.87 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Invesco S&P MidCap Value with Momt ETF Earnings Growth & XMVM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Invesco S&P MidCap Value with Momt ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):